[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GB0308469D0 - Pharmaceutical combination - Google Patents

Pharmaceutical combination

Info

Publication number
GB0308469D0
GB0308469D0 GB0308469A GB0308469A GB0308469D0 GB 0308469 D0 GB0308469 D0 GB 0308469D0 GB 0308469 A GB0308469 A GB 0308469A GB 0308469 A GB0308469 A GB 0308469A GB 0308469 D0 GB0308469 D0 GB 0308469D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical combination
pharmaceutical
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0308469A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB0308469A priority Critical patent/GB0308469D0/en
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of GB0308469D0 publication Critical patent/GB0308469D0/en
Priority to MXPA05010070A priority patent/MXPA05010070A/en
Priority to EP04724671A priority patent/EP1615635A1/en
Priority to BRPI0409127-2A priority patent/BRPI0409127A/en
Priority to CA002521902A priority patent/CA2521902A1/en
Priority to PCT/IB2004/001115 priority patent/WO2004089365A1/en
Priority to JP2006506461A priority patent/JP2006522790A/en
Priority to GT200400060A priority patent/GT200400060A/en
Priority to UY28260A priority patent/UY28260A1/en
Priority to PE2004000356A priority patent/PE20050086A1/en
Priority to CL2004000751A priority patent/CL2004000751A1/en
Priority to US10/819,604 priority patent/US20040204475A1/en
Priority to PA20048599901A priority patent/PA8599901A1/en
Priority to ARP040101192A priority patent/AR044009A1/en
Priority to NL1025908A priority patent/NL1025908C2/en
Priority to TW093109936A priority patent/TW200423929A/en
Ceased legal-status Critical Current

Links

GB0308469A 2003-04-11 2003-04-11 Pharmaceutical combination Ceased GB0308469D0 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
GB0308469A GB0308469D0 (en) 2003-04-11 2003-04-11 Pharmaceutical combination
MXPA05010070A MXPA05010070A (en) 2003-04-11 2004-03-31 Pharmaceutical combination comprising eletriptan and sodium bicarbonate.
EP04724671A EP1615635A1 (en) 2003-04-11 2004-03-31 Pharmaceutical combination comprising eletriptan and sodium bicarbonate
BRPI0409127-2A BRPI0409127A (en) 2003-04-11 2004-03-31 pharmaceutical combination comprising electriptan and sodium bicarbonate
CA002521902A CA2521902A1 (en) 2003-04-11 2004-03-31 Pharmaceutical combination comprising eletriptan and sodium bicarbonate
PCT/IB2004/001115 WO2004089365A1 (en) 2003-04-11 2004-03-31 Pharmaceutical combination comprising eletriptan and sodium bicarbonate
JP2006506461A JP2006522790A (en) 2003-04-11 2004-03-31 Pharmaceutical combination comprising eletriptan and sodium bicarbonate
GT200400060A GT200400060A (en) 2003-04-11 2004-04-01 PHARMACEUTICAL COMBINATION
UY28260A UY28260A1 (en) 2003-04-11 2004-04-06 PHARMACEUTICAL COMBINATION
PE2004000356A PE20050086A1 (en) 2003-04-11 2004-04-07 PHARMACEUTICAL COMBINATION INCLUDING ELETRIPTAN OR A PHARMACEUTICALLY ACCEPTABLE SALT AND SODIUM BICARBONATE
CL2004000751A CL2004000751A1 (en) 2003-04-11 2004-04-07 PHARMACEUTICAL COMBINATION CONTAINING (A) ELETRIPAN, OR ONE OF ITS SALTS, AND (B) SODIUM BICARBONATE; COMPOSITION AND PHARMACEUTICAL PRODUCT CONTAINING SUCH COMBINATION; AND ITS USE IN THE PREPARATION OF A USEFUL MEDICINAL PRODUCT FOR TREATMENT AND PREV
US10/819,604 US20040204475A1 (en) 2003-04-11 2004-04-07 Pharmaceutical combination
PA20048599901A PA8599901A1 (en) 2003-04-11 2004-04-07 PHARMACEUTICAL COMBINATION
ARP040101192A AR044009A1 (en) 2003-04-11 2004-04-07 PHARMACEUTICAL COMBINATION INCLUDING ELETRIPTAN AND SODIUM BICARBONATE
NL1025908A NL1025908C2 (en) 2003-04-11 2004-04-08 Pharmaceutical combination.
TW093109936A TW200423929A (en) 2003-04-11 2004-04-09 Pharmaceutical combination

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0308469A GB0308469D0 (en) 2003-04-11 2003-04-11 Pharmaceutical combination

Publications (1)

Publication Number Publication Date
GB0308469D0 true GB0308469D0 (en) 2003-05-21

Family

ID=9956666

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0308469A Ceased GB0308469D0 (en) 2003-04-11 2003-04-11 Pharmaceutical combination

Country Status (3)

Country Link
CL (1) CL2004000751A1 (en)
GB (1) GB0308469D0 (en)
GT (1) GT200400060A (en)

Also Published As

Publication number Publication date
GT200400060A (en) 2004-12-23
CL2004000751A1 (en) 2005-02-25

Similar Documents

Publication Publication Date Title
EG27104A (en) Pharmaceutical compounds
GB0315657D0 (en) Pharmaceutical compounds
HU0301154D0 (en) Pharmaceutical composition
GB0300427D0 (en) Pharmaceutical composition
GB0308511D0 (en) Pharmaceutical compounds
GB0307866D0 (en) Pharmaceutical composition
EP1699458A4 (en) Pharmaceutical composition
GB0329232D0 (en) Pharmaceutical composition
GB0317663D0 (en) Pharmaceutical composition
GB0317315D0 (en) Pharmaceutical compounds
GB0206505D0 (en) Pharmaceutical combination
GB0313766D0 (en) Pharmaceutical compounds
GB0300885D0 (en) Pharmaceutical composition
GB0308968D0 (en) Medicaments
GB0314733D0 (en) Medicaments
GB2401043B (en) Drug
GB0301736D0 (en) Pharmaceutical compounds
PL373409A1 (en) Pharmaceutical combination
GB0316889D0 (en) Pharmaceutical agents
GB0306933D0 (en) Pharmaceutical composition
GB0201520D0 (en) Pharmaceutical uses
GB0307869D0 (en) Pharmaceutical composition
GB0329617D0 (en) Pharmaceutical compounds
GB0307862D0 (en) Pharmaceutical composition
GB0307864D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)